It is a financial services public limited company based in Vishalgad, Maharashtra, India, established in 1941.
1941 | Vishalgad, Maharashtra, India | ActiveOriental Pharmaceutical Industries Limited, a active public limited company, was established on 11 March 1941 in Vishalgad, Maharashtra, India. Engaging in brokerage & trading services within the manufacturing sector, it holds CIN: U24239MH1941PLC003286. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹0.64 M.
Formerly known as The Oriental Pharmaceutical Industries Limited. It upholds a compliant status. Its leadership includes Youhaan Amol Kapadia (Director), Amol Jagdish Kapadia (Director), Dhau Gangaram Lambore (Director). Past directors included Sushila Jagdish Kapadia, Youhaan Amol Kapadia, Jagdish Jagmohandas Kapadia. It holds ₹50.27 Cr open charges and ₹25.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Factory Premisesoff Polson Ltd Ambaghat, Vishalgad, Maharashtra, 415101.
U24239MH1941PLC003286
003286
11 March 1941
₹6.00 M
₹0.64 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Oriental Pharmaceutical Industries Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Youhaan Amol Kapadia | Director | 19 Dec 2023 | Current |
| Amol Jagdish Kapadia | Director | 01 Sep 1995 | Current |
| Dhau Gangaram Lambore | Director | 13 Feb 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 13 Feb 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 19 Oct 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oriental Pharmaceutical Industries Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.59% decrease. The company also saw a substantial improvement in profitability, with a 32.57% increase in profit. The company's net worth dipped by a decrease of 1.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Oriental Pharmaceutical Industries had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹502,700,000.00
₹250,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2017 | Hdfc Bank Limited | ₹23.00 Cr | Open |
| 10 Nov 2017 | Hdfc Bank Limited | ₹27.27 Cr | Open |
| 31 Mar 2015 | Kotak Mahindra Bank Limited | ₹25.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Oriental Pharmaceutical Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Oriental Pharmaceutical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oriental Pharmaceutical Industries's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Oriental Pharmaceutical Industries Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Oriental Pharmaceutical Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Youhaan Amol Kapadia was appointed as a Director was appointed as a Director on 19 Dec 2023 & has been associated with this company since 2 years 27 days . was documented.
The activity A charge with Hdfc Bank Limited of Rs. 272.70 M registered on 10 Nov 2017 with Charge ID 100151793 was modified on 21 Apr 2022. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 230.00 M with Charge ID 100159148 was registered on 29 Dec 2017. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 272.70 M with Charge ID 100151793 was registered on 10 Nov 2017. was documented.
The CIN of Oriental Pharmaceutical Industries Limited is U24239MH1941PLC003286.
Oriental Pharmaceutical Industries Limited is headquartered at Factory Premisesoff Polson Ltd Ambaghat, Vishalgad, Maharashtra, 415101.
Oriental Pharmaceutical Industries Limited was incorporated on 11 March 1941.
The current directors of Oriental Pharmaceutical Industries Limited are
The primary industry of Oriental Pharmaceutical Industries Limited is Manufacturing.
Oriental Pharmaceutical Industries Limited is unlisted.
The authorized capital of Oriental Pharmaceutical Industries Limited is ₹6.00 M, and the paid-up capital is ₹0.64 M.
The compliance status of Oriental Pharmaceutical Industries Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX